{"database": "lobbying", "table": "lobbying_activities", "rows": [[1376190, "6f1f18de-64d6-4851-82f0-4da018a62f47", "Q1", "LIFE TECHNOLOGIES CORPORATION", 400391833, "LIFE TECHNOLOGIES CORPORATION", 2013, "first_quarter", "MED", "Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.\nNo bill numbers to date:  BETTER Care Act/Modernizing Laboratory Test Standards for Patients Act of 2011/Medical Testing Availability Act;  Provisions regarding lab developed tests.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, 100000, 0, 0, "2013-04-18T09:08:50.193000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1376190"], "units": {}, "query_ms": 20.058768001035787, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}